• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

1-芳基尿嘧啶支架中的稳定C-N轴手性以及PDE4抑制剂阻转异构体之间体外代谢清除率的差异。

Stable C-N axial chirality in 1-aryluracil scaffold and differences in in vitro metabolic clearance between atropisomers of PDE4 inhibitor.

作者信息

Hasegawa Futoshi, Kawamura Kazushi, Tsuchikawa Hiroshi, Murata Michio

机构信息

Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan.

Department of Chemistry, Graduate School of Science, Osaka University, 1-1 Machikaneyama, Toyonaka, Osaka 560-0043, Japan.

出版信息

Bioorg Med Chem. 2017 Aug 15;25(16):4506-4511. doi: 10.1016/j.bmc.2017.06.042. Epub 2017 Jun 27.

DOI:10.1016/j.bmc.2017.06.042
PMID:28698053
Abstract

We report herein the stable C-N axial chirality in a 1-phenyl-6-aminouracil scaffold owing to the presence of various functional groups at the ortho-position of the N(1)-phenyl group. Racemic 1-phenyl-6-aminouracils were first separated by chiral HPLC or converting them to the corresponding diastereomers using a chiral resolving agent. We then determined the rotational barrier of each atropisomer by a thermal racemization method and found that these compounds have rotational barriers similar to other C-N axially chiral biaryls. In addition, there was a good correlation between the rotational barriers and van der Waals radii of an ortho-substituent of the N(1)-phenyl group. To explore the possibility of the chiral 1-phenyl-6-aminouracil scaffold as a drug lead, we synthesized both atropisomers as phosphodiesterase-4 inhibitors 10. The atropisomers showed significantly different metabolic stabilities while their PDE4 inhibitory activities were somewhat similar. This finding demonstrates the potential utility of stable C-N bond atropisomers in the development of chiral drugs.

摘要

我们在此报告,由于N(1)-苯基邻位存在各种官能团,1-苯基-6-氨基尿嘧啶支架中存在稳定的C-N轴手性。外消旋1-苯基-6-氨基尿嘧啶首先通过手性高效液相色谱法分离,或使用手性拆分剂将其转化为相应的非对映异构体。然后,我们通过热消旋化方法测定了每种阻转异构体的旋转势垒,发现这些化合物的旋转势垒与其他C-N轴手性联芳基类似。此外,旋转势垒与N(1)-苯基邻位取代基的范德华半径之间存在良好的相关性。为了探索手性1-苯基-6-氨基尿嘧啶支架作为药物先导物的可能性,我们合成了两种阻转异构体作为磷酸二酯酶-4抑制剂10。这些阻转异构体表现出显著不同的代谢稳定性,而它们的PDE4抑制活性有些相似。这一发现证明了稳定的C-N键阻转异构体在开发手性药物中的潜在效用。

相似文献

1
Stable C-N axial chirality in 1-aryluracil scaffold and differences in in vitro metabolic clearance between atropisomers of PDE4 inhibitor.1-芳基尿嘧啶支架中的稳定C-N轴手性以及PDE4抑制剂阻转异构体之间体外代谢清除率的差异。
Bioorg Med Chem. 2017 Aug 15;25(16):4506-4511. doi: 10.1016/j.bmc.2017.06.042. Epub 2017 Jun 27.
2
Discovery of novel inhibitors of phosphodiesterase 4 with 1-phenyl-3,4-dihydroisoquinoline scaffold: Structure-based drug design and fragment identification.发现具有 1-苯基-3,4-二氢异喹啉骨架的磷酸二酯酶 4 的新型抑制剂:基于结构的药物设计和片段鉴定。
Bioorg Med Chem Lett. 2019 Nov 15;29(22):126720. doi: 10.1016/j.bmcl.2019.126720. Epub 2019 Oct 5.
3
Selaginpulvilins A-D, new phosphodiesterase-4 inhibitors with an unprecedented skeleton from Selaginella pulvinata.卷柏素 A-D,来自卷柏的新型磷酸二酯酶-4 抑制剂,具有前所未有的骨架。
Org Lett. 2014 Jan 3;16(1):282-5. doi: 10.1021/ol403282f. Epub 2013 Dec 12.
4
Pd-mediated functionalization of polysubstituted pyrroles: their evaluation as potential inhibitors of PDE4.钯介导的多取代吡咯的功能化:作为潜在 PDE4 抑制剂的评估。
Bioorg Med Chem Lett. 2012 Sep 1;22(17):5639-47. doi: 10.1016/j.bmcl.2012.06.100. Epub 2012 Jul 20.
5
Asymmetric Total Synthesis and Biological Evaluation of the Natural PDE4 Inhibitor Toddacoumalone.不对称全合成及天然 PDE4 抑制剂 Toddacoumalone 的生物评价。
Org Lett. 2020 Jan 17;22(2):584-588. doi: 10.1021/acs.orglett.9b04355. Epub 2020 Jan 6.
6
Design and synthesis of 4,5,6,7-tetrahydro-1H-1,2-diazepin-7-one derivatives as a new series of Phosphodiesterase 4 (PDE4) inhibitors.4,5,6,7-四氢-1H-1,2-二氮杂卓-7-酮衍生物作为新型磷酸二酯酶4(PDE4)抑制剂的设计与合成
Bioorg Med Chem Lett. 2017 Jan 1;27(1):24-29. doi: 10.1016/j.bmcl.2016.11.040. Epub 2016 Nov 16.
7
Design, synthesis and biological evaluation of novel tetrahydroisoquinoline derivatives as potential PDE4 inhibitors.新型四氢异喹啉衍生物作为潜在PDE4抑制剂的设计、合成及生物学评价
Bioorg Med Chem Lett. 2015 Oct 15;25(20):4610-4. doi: 10.1016/j.bmcl.2015.08.043. Epub 2015 Aug 21.
8
Synthesis and bioactivity of phenyl substituted furan and oxazole carboxylic acid derivatives as potential PDE4 inhibitors.苯基取代呋喃和噁唑羧酸衍生物的合成及生物活性作为潜在的 PDE4 抑制剂。
Eur J Med Chem. 2020 Dec 1;207:112795. doi: 10.1016/j.ejmech.2020.112795. Epub 2020 Sep 4.
9
5-Aryluracils as potent GnRH antagonists-Characterization of atropisomers.
Bioorg Med Chem Lett. 2008 Jun 1;18(11):3344-9. doi: 10.1016/j.bmcl.2008.04.029. Epub 2008 Apr 15.
10
Synthesis and bioactivity of pyrazole and triazole derivatives as potential PDE4 inhibitors.作为潜在磷酸二酯酶4(PDE4)抑制剂的吡唑和三唑衍生物的合成及生物活性
Bioorg Med Chem Lett. 2016 Aug 1;26(15):3632-5. doi: 10.1016/j.bmcl.2016.06.002. Epub 2016 Jun 2.

引用本文的文献

1
Recent Progress in Cyclic Aryliodonium Chemistry: Syntheses and Applications.环状芳基碘鎓化学的最新进展:合成与应用
Chem Rev. 2023 Jan 17;123(4):1364-416. doi: 10.1021/acs.chemrev.2c00591.
2
Naphthylisoquinoline alkaloids, validated as hit multistage antiplasmodial natural products.作为验证有效的多阶段抗疟天然产物,原小檗碱型异喹啉生物碱。
Int J Parasitol Drugs Drug Resist. 2020 Aug;13:51-58. doi: 10.1016/j.ijpddr.2020.05.003. Epub 2020 May 24.